{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:07:41Z","timestamp":1790222861761,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T00:00:00Z","timestamp":1467936000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12886-016-0285-2","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T07:46:44Z","timestamp":1467964004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["\u03b2-Thalassemia and ocular implications: a systematic review"],"prefix":"10.1186","volume":"16","author":[{"given":"Aliki","family":"Liaska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Petrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos D.","family":"Georgakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramza","family":"Diamanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Papaconstantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menelaos G.","family":"Kanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Georgalas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,8]]},"reference":[{"key":"285_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1196\/annals.1345.003","volume":"1054","author":"EP Vichinsky","year":"2005","unstructured":"Vichinsky EP. Changing patterns of thalassemia worldwide. Ann N Y Acad Sci. 2005;1054:18\u201324.","journal-title":"Ann N Y Acad Sci"},{"key":"285_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1750-1172-5-11","volume":"5","author":"R Galanello","year":"2010","unstructured":"Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5:11.","journal-title":"Orphanet J Rare Dis"},{"key":"285_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2471\/BLT.06.036673","volume":"86","author":"B Modell","year":"2008","unstructured":"Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86:480\u20137.","journal-title":"Bull World Health Organ"},{"key":"285_CR4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJM199808133390701","volume":"339","author":"NF Olivieri","year":"1998","unstructured":"Olivieri NF, Brittenham GM, McLaren CE, Templeton DM, Cameron RG, McClelland RA, et al. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N Engl J Med. 1998;339:417\u201323.","journal-title":"N Engl J Med"},{"key":"285_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002280050584","volume":"55","author":"A Addis","year":"1999","unstructured":"Addis A, Loebstein R, Koren G, Einarson TR. Meta-analytic review of the clinical effectiveness of oral deferiprone (l1). Eur J Clin Pharmacol. 1999;55:1\u20136.","journal-title":"Eur J Clin Pharmacol"},{"key":"285_CR6","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1182\/blood-2010-01-251348","volume":"115","author":"DJ Weatherall","year":"2010","unstructured":"Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010;115:4331\u20136.","journal-title":"Blood"},{"key":"285_CR7","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1056\/NEJMra050436","volume":"353","author":"D Rund","year":"2005","unstructured":"Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005;353:1135\u201346.","journal-title":"N Engl J Med"},{"key":"285_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000171088","volume":"120","author":"K Charafeddine","year":"2008","unstructured":"Charafeddine K, Isma\u2019eel H, Charafeddine M, Inati A, Koussa S, Naja M, et al. Survival and complications of beta-thalassemia in lebanon: a decade\u2019s experience of centralized care. Acta Haematol. 2008;120:112\u20136.","journal-title":"Acta Haematol"},{"key":"285_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/pbc.21028","volume":"48","author":"JP Chern","year":"2007","unstructured":"Chern JP, Su S, Lin KH, Chang SH, Lu MY, Jou ST, et al. Survival, mortality, and complications in patients with beta-thalassemia major in northern taiwan. Pediatr Blood Cancer. 2007;48:550\u20134.","journal-title":"Pediatr Blood Cancer"},{"key":"285_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1196\/annals.1345.006","volume":"1054","author":"C Borgna-Pignatti","year":"2005","unstructured":"Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, et al. Survival and complications in thalassemia. Ann N Y Acad Sci. 2005;1054:40\u20137.","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 1","key":"285_CR11","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.3109\/03630260903347336","volume":"33","author":"P Telfer","year":"2009","unstructured":"Telfer P. Update on survival in thalassemia major. Hemoglobin. 2009;33 Suppl 1:S76\u201380.","journal-title":"Hemoglobin"},{"key":"285_CR12","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(00)02357-6","volume":"355","author":"B Modell","year":"2000","unstructured":"Modell B, Khan M, Darlison M. Survival in beta-thalassaemia major in the uk: data from the uk thalassaemia register. Lancet (London, England). 2000;355:2051\u20132.","journal-title":"Lancet (London, England)"},{"key":"285_CR13","first-page":"1187","volume":"91","author":"P Telfer","year":"2006","unstructured":"Telfer P, Coen PG, Christou S, Hadjigavriel M, Kolnakou A, Pangalou E, et al. Survival of medically treated thalassemia patients in cyprus. Trends and risk factors over the period 1980\u20132004. Haematologica. 2006;91:1187\u201392.","journal-title":"Haematologica"},{"key":"285_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/ajh.20809","volume":"82","author":"EB Fung","year":"2007","unstructured":"Fung EB, Harmatz P, Milet M, Ballas SK, De Castro L, Hagar W, et al. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: a report from the multi-center study of iron overload. Am J Hematol. 2007;82:255\u201365.","journal-title":"Am J Hematol"},{"key":"285_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s002770050002","volume":"79","author":"H Cario","year":"2000","unstructured":"Cario H, Stahnke K, Sander S, Kohne E. Epidemiological situation and treatment of patients with thalassemia major in germany: results of the german multicenter beta-thalassemia study. Ann Hematol. 2000;79:7\u201312.","journal-title":"Ann Hematol"},{"key":"285_CR16","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3324\/haematol.2009.018051","volume":"95","author":"I Thuret","year":"2010","unstructured":"Thuret I, Pondarre C, Loundou A, Steschenko D, Girot R, Bachir D, et al. Complications and treatment of patients with beta-thalassemia in france: results of the national registry. Haematologica. 2010;95:724\u20139.","journal-title":"Haematologica"},{"key":"285_CR17","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1182\/blood-2010-08-300335","volume":"118","author":"EA Rachmilewitz","year":"2011","unstructured":"Rachmilewitz EA, Giardina PJ. How i treat thalassemia. Blood. 2011;118:3479\u201388.","journal-title":"Blood"},{"key":"285_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1182\/blood.V99.1.30","volume":"99","author":"A Aessopos","year":"2002","unstructured":"Aessopos A, Farmakis D, Loukopoulos D. Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta thalassemia and the sickling syndromes. Blood. 2002;99:30\u20135.","journal-title":"Blood"},{"key":"285_CR19","doi-asserted-by":"publisher","first-page":"710","DOI":"10.4103\/0301-4738.170986","volume":"63","author":"R Jafari","year":"2015","unstructured":"Jafari R, Heydarian S, Karami H, Shektaei MM, Dailami KN, Amiri AA, et al. Ocular abnormalities in multi-transfused beta-thalassemia patients. Indian J Ophthalmol. 2015;63:710\u20135.","journal-title":"Indian J Ophthalmol"},{"key":"285_CR20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ophtha.2013.10.016","volume":"121","author":"G Barteselli","year":"2014","unstructured":"Barteselli G, Dell\u2019arti L, Finger RP, Charbel Issa P, Marcon A, Vezzola D, et al. The spectrum of ocular alterations in patients with beta-thalassemia syndromes suggests a pathology similar to pseudoxanthoma elasticum. Ophthalmology. 2014;121:709\u201318.","journal-title":"Ophthalmology"},{"key":"285_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1444-0938.2010.00579.x","volume":"94","author":"MH Nowroozzadeh","year":"2011","unstructured":"Nowroozzadeh MH, Kalantari Z, Namvar K, Meshkibaf MH. Ocular refractive and biometric characteristics in patients with thalassaemia major. Clin Exp Optom. 2011;94:361\u20136.","journal-title":"Clin Exp Optom"},{"key":"285_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4103\/0301-4738.60083","volume":"58","author":"R Taneja","year":"2010","unstructured":"Taneja R, Malik P, Sharma M, Agarwal MC. Multiple transfused thalassemia major: ocular manifestations in a hospital-based population. Indian J Ophthalmol. 2010;58:125\u201330.","journal-title":"Indian J Ophthalmol"},{"key":"285_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.4103\/0301-4738.67061","volume":"58","author":"J Jethani","year":"2010","unstructured":"Jethani J, Marwah K, Patel S, Shah B. Ocular abnormalities in patients with beta thalassemia on transfusion and chelation therapy: our experience. Indian J Ophthalmol. 2010;58:451\u20132.","journal-title":"Indian J Ophthalmol"},{"key":"285_CR24","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/00003226-200310000-00002","volume":"22","author":"SP Gartaganis","year":"2003","unstructured":"Gartaganis SP, Georgakopoulos CD, Exarchou A, Mela EK, Psachoulia C, Eliopoulou MI, et al. Alterations in conjunctival cytology and tear film dysfunction in patients with beta-thalassemia. Cornea. 2003;22:591\u20137.","journal-title":"Cornea"},{"key":"285_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1023\/A:1001728512515","volume":"96","author":"C Jiang","year":"1998","unstructured":"Jiang C, Hansen RM, Gee BE, Kurth SS, Fulton AB. Rod and rod mediated function in patients with beta-thalassemia major. Doc Ophthalmol. 1998;96:333\u201345.","journal-title":"Doc Ophthalmol"},{"key":"285_CR26","first-page":"38","volume":"92","author":"JA Dennerlein","year":"1995","unstructured":"Dennerlein JA, Lang GE, Stahnke K, Kleihauer E, Lang GK. ocular findings in desferal therapy. Der Ophthalmol. 1995;92:38\u201342.","journal-title":"Der Ophthalmol"},{"key":"285_CR27","first-page":"23","volume":"13","author":"R Sorcinelli","year":"1990","unstructured":"Sorcinelli R, Sitzia A, Figus A, Lai ME. Ocular findings in beta-thalassemia. Metab Pediatr Syst Ophthalmol (New York, NY : 1985). 1990;13:23\u20135.","journal-title":"Metab Pediatr Syst Ophthalmol (New York, NY : 1985)"},{"key":"285_CR28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/0002-9394(89)90864-7","volume":"108","author":"S Gartaganis","year":"1989","unstructured":"Gartaganis S, Ismiridis K, Papageorgiou O, Beratis NG, Papanastasiou D. Ocular abnormalities in patients with beta thalassemia. Am J Ophthalmol. 1989;108:699\u2013703.","journal-title":"Am J Ophthalmol"},{"key":"285_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/adc.63.3.250","volume":"63","author":"S Virgiliis De","year":"1988","unstructured":"De Virgiliis S, Congia M, Turco MP, Frau F, Dessi C, Argiolu F, et al. Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia. Arch Dis Child. 1988;63:250\u20135.","journal-title":"Arch Dis Child"},{"key":"285_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000309871","volume":"196","author":"C Gelmi","year":"1988","unstructured":"Gelmi C, Borgna-Pignatti C, Franchin S, Tacchini M, Trimarchi F. Electroretinographic and visual-evoked potential abnormalities in patients with beta-thalassemia major. Ophthalmologica. 1988;196:29\u201334.","journal-title":"Ophthalmologica"},{"key":"285_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0140-6736(83)90170-8","volume":"2","author":"SC Davies","year":"1983","unstructured":"Davies SC, Marcus RE, Hungerford JL, Miller MH, Arden GB, Huehns ER. Ocular toxicity of high-dose intravenous desferrioxamine. Lancet (London, England). 1983;2:181\u20134.","journal-title":"Lancet (London, England)"},{"key":"285_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/bjo.70.5.373","volume":"70","author":"AH Rahi","year":"1986","unstructured":"Rahi AH, Hungerford JL, Ahmed AI. Ocular toxicity of desferrioxamine: light microscopic histochemical and ultrastructural findings. Br J Ophthalmol. 1986;70:373\u201381.","journal-title":"Br J Ophthalmol"},{"key":"285_CR33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0161-6420(01)00947-2","volume":"109","author":"R Haimovici","year":"2002","unstructured":"Haimovici R, D\u2019Amico DJ, Gragoudas ES, Sokol S. The expanded clinical spectrum of deferoxamine retinopathy. Ophthalmology. 2002;109:164\u201371.","journal-title":"Ophthalmology"},{"key":"285_CR34","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.ajo.2006.04.030","volume":"142","author":"A Taher","year":"2006","unstructured":"Taher A, Bashshur Z, Shamseddeen WA, Abdulnour RE, Aoun E, Koussa S, et al. Ocular findings among thalassemia patients. Am J Ophthalmol. 2006;142:704\u20135.","journal-title":"Am J Ophthalmol"},{"key":"285_CR35","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1097\/IAE.0000000000000073","volume":"34","author":"F Viola","year":"2014","unstructured":"Viola F, Barteselli G, Dell\u2019Arti L, Vezzola D, Mapelli C, Villani E, et al. Multimodal imaging in deferoxamine retinopathy. Retina (Philadelphia, Pa). 2014;34:1428\u201338.","journal-title":"Retina (Philadelphia, Pa)"},{"key":"285_CR36","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.ophtha.2012.01.039","volume":"119","author":"F Viola","year":"2012","unstructured":"Viola F, Barteselli G, Dell\u2019arti L, Vezzola D, Villani E, Mapelli C, et al. Abnormal fundus autofluorescence results of patients in long-term treatment with deferoxamine. Ophthalmology. 2012;119:1693\u2013700.","journal-title":"Ophthalmology"},{"key":"285_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3109\/08820538.2013.839811","volume":"29","author":"A Aksoy","year":"2014","unstructured":"Aksoy A, Aslan L, Aslankurt M, Eser O, Garipardic M, Okumus S, et al. Retinal fiber layer thickness in children with thalessemia major and iron deficiency anemia. Semin Ophthalmol. 2014;29:22\u20136.","journal-title":"Semin Ophthalmol"},{"key":"285_CR38","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/sj.eye.6700352","volume":"17","author":"C Incorvaia","year":"2003","unstructured":"Incorvaia C, Parmeggiani F, Costagliola C, Perri P, D\u2019Angelo S, Sebastiani A. Quantitative evaluation of the retinal venous tortuosity in chronic anaemic patients affected by beta-thalassaemia major. Eye (London, England). 2003;17:324\u20139.","journal-title":"Eye (London, England)"},{"key":"285_CR39","first-page":"118","volume":"7","author":"A Aksoy","year":"2014","unstructured":"Aksoy A, Aslankurt M, Aslan L, Gul O, Garipardic M, Celik O, et al. Ocular findings in children with thalassemia major in eastern mediterranean. Int J Ophthalmol. 2014;7:118\u201321.","journal-title":"Int J Ophthalmol"},{"key":"285_CR40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4103\/0301-4738.98714","volume":"60","author":"S Simon","year":"2012","unstructured":"Simon S, Athanasiov PA, Jain R, Raymond G, Gilhotra JS. Desferrioxamine-related ocular toxicity: a case report. Indian J Ophthalmol. 2012;60:315\u20137.","journal-title":"Indian J Ophthalmol"},{"key":"285_CR41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10633-010-9236-z","volume":"121","author":"MA Genead","year":"2010","unstructured":"Genead MA, Fishman GA, Anastasakis A, Lindeman M. Macular vitelliform lesion in desferrioxamine-related retinopathy. Doc Ophthalmol. 2010;121:161\u20136.","journal-title":"Doc Ophthalmol"},{"key":"285_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12185-007-0014-y","volume":"87","author":"A Aessopos","year":"2008","unstructured":"Aessopos A, Floudas CS, Kati M, Tsironi M, Giakoumi X, Livir-Rallatos C, et al. Loss of vision associated with angioid streaks in beta-thalassemia intermedia. Int J Hematol. 2008;87:35\u20138.","journal-title":"Int J Hematol"},{"key":"285_CR43","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.jcrs.2007.05.011","volume":"33","author":"I Athanasiadis","year":"2007","unstructured":"Athanasiadis I, Konstantinidis A, Kyprianou I, Robinson R, Moschou V, Kouzi-Koliakos K. Rapidly progressing bilateral cataracts in a patient with beta thalassemia and pellagra. J Cataract Refract Surg. 2007;33:1659\u201361.","journal-title":"J Cataract Refract Surg"},{"key":"285_CR44","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/1752-1947-5-466","volume":"5","author":"MG Ishaq","year":"2011","unstructured":"Ishaq MG, Shabbir FA. Takayasu\u2019s arteritis presenting with temporary loss of vision in a 23-year-old woman with beta thalassemia trait: a case report. J Med Case Rep. 2011;5:466.","journal-title":"J Med Case Rep"},{"key":"285_CR45","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1034\/j.1600-0420.2000.078005512.x","volume":"78","author":"SP Gartaganis","year":"2000","unstructured":"Gartaganis SP, Zoumbos N, Koliopoulos JX, Mela EK. Contrast sensitivity function in patients with beta-thalassemia major. Acta Ophthalmol Scand. 2000;78:512\u20135.","journal-title":"Acta Ophthalmol Scand"},{"key":"285_CR46","first-page":"633","volume":"8","author":"DSM Abdel-Malak","year":"2012","unstructured":"Abdel-Malak DSM, Dabbous OAE, Saif MYS, Saif ATS. Ocular manifestations in children with \u03b2 thalassemia major and visual toxicity of iron chelating agents. J Am Sci. 2012;8:633\u20138.","journal-title":"J Am Sci"},{"key":"285_CR47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/GIM.0b013e3181cd68ed","volume":"12","author":"A Cao","year":"2010","unstructured":"Cao A, Galanello R. Beta-thalassemia. Genet Med. 2010;12:61\u201376.","journal-title":"Genet Med"},{"key":"285_CR48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1006\/exer.1996.0142","volume":"63","author":"S Shimmura","year":"1996","unstructured":"Shimmura S, Suematsu M, Shimoyama M, Tsubota K, Oguchi Y, Ishimura Y. Subthreshold uv radiation-induced peroxide formation in cultured corneal epithelial cells: the protective effects of lactoferrin. Exp Eye Res. 1996;63:519\u201326.","journal-title":"Exp Eye Res"},{"key":"285_CR49","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1182\/blood.V88.9.3608.bloodjournal8893608","volume":"88","author":"MA Livrea","year":"1996","unstructured":"Livrea MA, Tesoriere L, Pintaudi AM, Calabrese A, Maggio A, Freisleben HJ, et al. Oxidative stress and antioxidant status in beta-thalassemia major: Iron overload and depletion of lipid-soluble antioxidants. Blood. 1996;88:3608\u201314.","journal-title":"Blood"},{"key":"285_CR50","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0021-9150(97)00300-6","volume":"137","author":"L Tesoriere","year":"1998","unstructured":"Tesoriere L, D\u2019Arpa D, Maggio A, Giaccone V, Pedone E, Livrea MA. Oxidation resistance of ldl is correlated with vitamin e status in beta-thalassemia intermedia. Atherosclerosis. 1998;137:429\u201335.","journal-title":"Atherosclerosis"},{"key":"285_CR51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1447-073X.2007.00195.x","volume":"83","author":"M Repanti","year":"2008","unstructured":"Repanti M, Gartaganis SP, Nikolakopoulou NM, Ellina A, Papanastasiou DA. Study of the eye and lacrimal glands in experimental iron overload in rats in vivo. Anat Sci Int. 2008;83:11\u20136.","journal-title":"Anat Sci Int"},{"key":"285_CR52","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1444-0938.2009.00385.x","volume":"92","author":"M Mehdizadeh","year":"2009","unstructured":"Mehdizadeh M, Nowroozzadeh MH. Posterior subcapsular opacity in two patients with thalassaemia major following deferiprone consumption. Clin Exp Optom. 2009;92:392\u20134.","journal-title":"Clin Exp Optom"},{"key":"285_CR53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fgene.2013.00014","volume":"4","author":"M Gliem","year":"2013","unstructured":"Gliem M, Zaeytijd JD, Finger RP, Holz FG, Leroy BP, Charbel IP. An update on the ocular phenotype in patients with pseudoxanthoma elasticum. Front Genet. 2013;4:14.","journal-title":"Front Genet"},{"key":"285_CR54","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/BF00409836","volume":"203","author":"OA Jensen","year":"1977","unstructured":"Jensen OA. Bruch\u2019s membrane in pseudoxanthoma elasticum. Histochemical, ultrastructural, and x-ray microanalytical study of the membrane and angioid streak areas. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1977;203:311\u201320.","journal-title":"Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"285_CR55","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0039-6257(77)90041-8","volume":"21","author":"AH Friedman","year":"1977","unstructured":"Friedman AH, Beckerman B, Gold DH, Walsh JB, Gartner S. Drusen of the optic disc. Surv Ophthalmol. 1977;21:373\u201390.","journal-title":"Surv Ophthalmol"},{"key":"285_CR56","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S0002-9394(14)73300-8","volume":"108","author":"A Aessopos","year":"1989","unstructured":"Aessopos A, Stamatelos G, Savvides P, Kavouklis E, Gabriel L, Rombos I, et al. Angioid streaks in homozygous beta thalassemia. Am J Ophthalmol. 1989;108:356\u20139.","journal-title":"Am J Ophthalmol"},{"key":"285_CR57","first-page":"115","volume":"7","author":"G Theodossiadis","year":"1984","unstructured":"Theodossiadis G, Ladas I, Koutsandrea C, Damanakis A, Petroutsos G. thalassemia and macular subretinal neovascularization. J Fr Ophtalmol. 1984;7:115\u20138.","journal-title":"J Fr Ophtalmol"},{"key":"285_CR58","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/archopht.1983.01040020051008","volume":"101","author":"ML Aisen","year":"1983","unstructured":"Aisen ML, Bacon BR, Goodman AM, Chester EM. Retinal abnormalities associated with anemia. Arch Ophthalmol (Chicago, Ill : 1960). 1983;101:1049\u201352.","journal-title":"Arch Ophthalmol (Chicago, Ill : 1960)"},{"key":"285_CR59","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","volume":"115","author":"AT Taher","year":"2010","unstructured":"Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the optimal care study. Blood. 2010;115:1886\u201392.","journal-title":"Blood"},{"key":"285_CR60","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archinte.1971.00310190037002","volume":"128","author":"MF Goldberg","year":"1971","unstructured":"Goldberg MF, Charache S, Acacio I. Ophthalmologic manifestations of sickle cell thalassemia. Arch Intern Med. 1971;128:33\u20139.","journal-title":"Arch Intern Med"},{"key":"285_CR61","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0002-9394(14)70064-9","volume":"117","author":"A Aessopos","year":"1994","unstructured":"Aessopos A, Voskaridou E, Kavouklis E, Vassilopoulos G, Rombos Y, Gavriel L, et al. Angioid streaks in sickle-thalassemia. Am J Ophthalmol. 1994;117:589\u201392.","journal-title":"Am J Ophthalmol"},{"key":"285_CR62","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0181-5512(05)81070-8","volume":"28","author":"A Fanny","year":"2005","unstructured":"Fanny A, Coulibaly F, Gbe K, Meite M, Adjorlolo C, Konan-Toure ML, et al. [sickle cell beta-thalassemia leading to serious ischemic retinopathy: a study of 18 patients in abidjan]. J Fr Ophtalmol. 2005;28:391\u20135.","journal-title":"J Fr Ophtalmol"},{"key":"285_CR63","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2165\/00002018-199717060-00006","volume":"17","author":"JB Porter","year":"1997","unstructured":"Porter JB. A risk-benefit assessment of iron-chelation therapy. Drug Saf. 1997;17:407\u201321.","journal-title":"Drug Saf"},{"key":"285_CR64","volume-title":"Toxicology of the eye: drugs, chemicals, plants, venoms","author":"WM Grant","year":"1974","unstructured":"Grant WM. Toxicology of the eye: drugs, chemicals, plants, venoms. Springfield: Charles C. Thomas; 1974."},{"key":"285_CR65","doi-asserted-by":"publisher","first-page":"249617","DOI":"10.1155\/2015\/249617","volume":"2015","author":"M Nicola Di","year":"2015","unstructured":"Di Nicola M, Barteselli G, Dell\u2019Arti L, Ratiglia R, Viola F. Functional and structural abnormalities in deferoxamine retinopathy: a review of the literature. BioMed Res Int. 2015;2015:249617.","journal-title":"BioMed Res Int"},{"key":"285_CR66","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1034\/j.1600-0609.2003.00073.x","volume":"70","author":"V Bansal","year":"2003","unstructured":"Bansal V, Elgarbly I, Ghanchi FD, Atkinson PL. Bull\u2019s eye maculopathy with deferoxamine. Eur J Haematol. 2003;70:420\u20131.","journal-title":"Eur J Haematol"},{"key":"285_CR67","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0161-6420(84)34267-1","volume":"91","author":"V Lakhanpal","year":"1984","unstructured":"Lakhanpal V, Schocket SS, Jiji R. Deferoxamine (desferal)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy. Ophthalmology. 1984;91:443\u201351.","journal-title":"Ophthalmology"},{"key":"285_CR68","first-page":"153","volume":"20","author":"RB Orton","year":"1985","unstructured":"Orton RB, de Veber LL, Sulh HM. Ocular and auditory toxicity of long-term, high-dose subcutaneous deferoxamine therapy. Can J Ophthalmol. 1985;20:153\u20136.","journal-title":"Can J Ophthalmol"},{"key":"285_CR69","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0022-3476(05)80556-6","volume":"117","author":"A Cohen","year":"1990","unstructured":"Cohen A, Martin M, Mizanin J, Konkle DF, Schwartz E. Vision and hearing during deferoxamine therapy. J Pediatr. 1990;117:326\u201330.","journal-title":"J Pediatr"},{"key":"285_CR70","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1136\/bjo.73.1.42","volume":"73","author":"H Pall","year":"1989","unstructured":"Pall H, Blake DR, Winyard P, Lunec J, Williams A, Good PA, et al. Ocular toxicity of desferrioxamine--an example of copper promoted auto-oxidative damage? Br J Ophthalmol. 1989;73:42\u20137.","journal-title":"Br J Ophthalmol"},{"key":"285_CR71","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/ajh.10348","volume":"73","author":"TB Chaston","year":"2003","unstructured":"Chaston TB, Richardson DR. Iron chelators for the treatment of iron overload disease: relationship between structure, redox activity, and toxicity. Am J Hematol. 2003;73:200\u201310.","journal-title":"Am J Hematol"},{"key":"285_CR72","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/bjo.2005.080119","volume":"90","author":"TY Lai","year":"2006","unstructured":"Lai TY, Lee GK, Chan WM, Lam DS. Rapid development of severe toxic retinopathy associated with continuous intravenous deferoxamine infusion. Br J Ophthalmol. 2006;90:243\u20134.","journal-title":"Br J Ophthalmol"},{"key":"285_CR73","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2141.1989.tb07761.x","volume":"73","author":"JB Porter","year":"1989","unstructured":"Porter JB, Jaswon MS, Huehns ER, East CA, Hazell JW. Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosage. Br J Haematol. 1989;73:403\u20139.","journal-title":"Br J Haematol"},{"key":"285_CR74","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1167\/iovs.09-3541","volume":"50","author":"P Charbel Issa","year":"2009","unstructured":"Charbel Issa P, Finger RP, Holz FG, Scholl HP. Multimodal imaging including spectral domain oct and confocal near infrared reflectance for characterization of outer retinal pathology in pseudoxanthoma elasticum. Invest Ophthalmol Vis Sci. 2009;50:5913\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"285_CR75","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2415-14-88","volume":"14","author":"C-H Wu","year":"2014","unstructured":"Wu C-H, Yang C-P, Lai C-C, Wu W-C, Chen Y-H. Deferoxamine retinopathy: spectral domain-optical coherence tomography findings. BMC Ophthalmol. 2014;14:88.","journal-title":"BMC Ophthalmol"},{"key":"285_CR76","doi-asserted-by":"crossref","unstructured":"El-Shazly AAEF, Elkitkat RS, Ebeid WM, Deghedy MR. Correlation between subfoveal choroidal thickness and foveal thickness in thalassemic patients. Retina (Philadelphia, Pa.); 2016. in press.","DOI":"10.1097\/IAE.0000000000000970"},{"key":"285_CR77","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/bjo.48.10.517","volume":"48","author":"JL Smith","year":"1964","unstructured":"Smith JL, Gass JD, Justice Jr J. Fluorescein fundus photography of angioid streaks. Br J Ophthalmol. 1964;48:517\u201321.","journal-title":"Br J Ophthalmol"},{"key":"285_CR78","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1136\/bjo.55.12.833","volume":"55","author":"B Patnaik","year":"1971","unstructured":"Patnaik B, Malik SR. Fluorescein fundus photography of angioid streaks. Br J Ophthalmol. 1971;55:833\u20137.","journal-title":"Br J Ophthalmol"},{"key":"285_CR79","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/archopht.1975.01010020749003","volume":"93","author":"JL Federman","year":"1975","unstructured":"Federman JL, Shields JA, Tomer TL. Angioid streaks. Ii. Fluorescein angiographic features. Arch Ophthalmol (Chicago, Ill : 1960). 1975;93:951\u201362.","journal-title":"Arch Ophthalmol (Chicago, Ill : 1960)"},{"key":"285_CR80","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1136\/bjo.2009.162644","volume":"94","author":"J Zaeytijd De","year":"2010","unstructured":"De Zaeytijd J, Vanakker OM, Coucke PJ, De Paepe A, De Laey JJ, Leroy BP. Added value of infrared, red-free and autofluorescence fundus imaging in pseudoxanthoma elasticum. Br J Ophthalmol. 2010;94:479\u201386.","journal-title":"Br J Ophthalmol"},{"key":"285_CR81","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000345734","volume":"130","author":"KM Musallam","year":"2013","unstructured":"Musallam KM, Angastiniotis M, Eleftheriou A, Porter JB. Cross-talk between available guidelines for the management of patients with beta-thalassemia major. Acta Haematol. 2013;130:64\u201373.","journal-title":"Acta Haematol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-016-0285-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-016-0285-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-016-0285-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-016-0285-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T13:20:57Z","timestamp":1600867257000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-016-0285-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,8]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["285"],"URL":"https:\/\/doi.org\/10.1186\/s12886-016-0285-2","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,8]]},"article-number":"102"}}